Predictive value of elevated soluble CD40 ligand in patients undergoing primary angioplasty for ST-segment elevation myocardial infarction

PUSUROGLU H., AKGUL O., ERTURK M., Uyarel H., BULUT U., AKKAYA E., ...More

CORONARY ARTERY DISEASE, vol.25, no.7, pp.558-564, 2014 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 25 Issue: 7
  • Publication Date: 2014
  • Doi Number: 10.1097/mca.0000000000000142
  • Journal Name: CORONARY ARTERY DISEASE
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.558-564
  • Keywords: myocardial infarction, primary angioplasty, soluble CD40 ligand, ACUTE CORONARY SYNDROMES, ARTERY-DISEASE, CLINICAL-IMPLICATIONS, RISK, ATHEROSCLEROSIS, PATHOGENESIS, INFLAMMATION, MECHANISMS, BIOMARKERS, EVENTS
  • Recep Tayyip Erdoğan University Affiliated: Yes

Abstract

Objectives The aim of this study was to evaluate the prognostic value of soluble CD40 ligand (sCD40L) in patients with ST-segment elevation myocardial infarction (STEMI) undergoing a primary percutaneous coronary intervention (PCI).